JOYCE BYERS: Open Payments
NPI 1477746261 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 13 payments from 7 companies in 2025. Trend: 2023 $558 · 2024 $621 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $73 |
| Tandem Diabetes Care, Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Dexcom, Inc. | 1 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| CeQur Corporation | 1 | $27 |
| Insulet Corporation | 1 | $24 |
Products named: Ozempic, t:slim X2 Insulin Pump with Control-IQ, CRENESSITY, Dexcom G6 Transmitter, JARDIANCE, CeQur Simplicity, Omnipod.
Industry payments across MI — which companies pay providers there.
